vcvibes

Kineticos Life Sciences Management LLC

SEC exempt reporting adviser (venture capital exemption).

HQ
NC

Kineticos Life Sciences Management LLC invests in life science companies, including outsourced pharma, tools and equipment. It offers expertise, industry insight, and access to a network of experts to support management teams through each stage of the business life cycle. Its team includes Founder and Managing Partner Shailesh Maingi, along with Principals, a Venture Partner, and an Analyst. Its portfolio spans CDMOs, cell and gene therapy, and anti-infective and neurological companies.

New fund likely raising soon

The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.

01 · Says / Does

TagSaysDoes
StagesNot statedNot enough dated deals
SectorsBiotech, Medical devicesNot enough dated deals
RegionsGlobalNot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
Kineticos Disruptor Fund II, L.P.
2021$55.2M to $100M (Form D)Late investment period

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. https://www.kineticos.com/
  2. https://www.kineticos.com/contact-us/
  3. https://www.kineticos.com/kineticos-disruptor-fund-series/
  4. https://www.kineticos.com/team/
  5. https://www.kineticos.com/portfolio/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 25, 2026